Table of Contents

October 6, 2009; 151 (7)

Articles

  • Few data are available on the effectiveness of nonpharmaceutical interventions for preventing influenza virus transmission. In this cluster randomized trial of 259 people with confirmed influenza virus infection and 794 household contacts, hand washing and facemasks seemed to prevent influenza virus transmission when healthy people started these measures within 36 hours of symptom onset in an infected family member. Although adherence to the interventions varied, these findings suggest that nonpharmaceutical interventions may help to mitigate pandemic and interpandemic influenza.

  • Obstructive sleep apnea (OSA) is associated with sleepiness and poor concentration, symptoms that could impair driving performance. These investigators evaluated simulated driving performance in 38 patients with untreated OSA and 20 control participants under 3 conditions: unrestricted sleep, sleep restriction, and consumption of alcohol. Steering deviation during simulated driving was 40% greater among patients with OSA after sleep restriction and alcohol intake, and patients with OSA crashed more frequently than control participants overall and after sleep restriction and alcohol consumption.

  • Whether practices that have structural features characteristic of patient-centered medical homes (electronic health records, enhanced access, and ongoing performance feedback) have higher performance on measures of primary care quality is unknown. In studying 412 practices and quality measures related to diabetes, depression, prevention, and overuse of selected tests and treatments, the investigators observed that use of more sophisticated electronic health records was associated with better screening and diabetes care, but other associations between structural capabilities and quality were weaker or absent.

Review

  • Neuraminidase inhibitors are a key element of public health strategies to prevent and treat pandemic influenza. This review of 7 randomized, placebo-controlled trials found that extended-duration (>4 weeks) prophylaxis with either oseltamivir or zanamivir prevented symptomatic influenza but not asymptomatic influenza virus infection. The overall number of adverse side effects was similar for patients receiving neuraminidase inhibitors or placebo, except that oseltamivir caused more nausea and vomiting. The trials included only immunocompetent white and Japanese adults.

Clinical Guidelines

  • The U.S. Preventive Services Task Force (USPSTF) has issued a recommendation statement on the use of 9 nontraditional risk factors (high-sensitivity C-reactive protein [CRP], ankle–brachial index, leukocyte count, fasting blood glucose level, periodontal disease, carotid intima–media thickness, coronary artery calcification on electron-beam computed tomography, homocysteine level, and lipoprotein[a] level) in assessing coronary heart disease (CHD) risk in asymptomatic persons. It concludes that the current evidence is insufficient to assess the balance of benefits and harms of using these nontraditional risk factors to screen asymptomatic men and women with no history of CHD to prevent CHD events (I statement).

  • To support the USPSTF recommendation statement in this issue, Buckley and colleagues systematically reviewed evidence on the use of CRP in assessing CHD risk in persons at intermediate risk based on traditional risk factors. They found strong evidence that CRP is associated with CHD events and moderate, consistent evidence that adding CRP to risk prediction models among initially intermediate-risk persons improves risk stratification. Evidence was insufficient to assess whether reducing CRP levels prevents CHD events.

  • To support the USPSTF recommendation statement in this issue, Helfand and associates evaluated the clinical usefulness of 9 new risk factors for CHD. Available evidence varied among these factors. Although CRP was the best candidate for use in screening, evidence that changes in CRP level lead to primary prevention of CHD events is inadequate. Thus, the current evidence does not support routine use of any of the 9 risk factors for further stratification of intermediate-risk persons.

Editorials

  • The new Editor describes her vision for the journal, including the role of technology in medical journals and Annals' future as an intellectual gathering place for internal medicine.

  • The editorialist discusses the leadership of Christine Laine, Annals' new Editor, in the context of changes in Annals content over time and the future of medical journalism.

Letters

Ad Libitum

Medical Notices

Summaries for Patients

In the Clinic